Skip to main content


Research Faculty

Areas of Special Interest
C. Michael Cotten, MD, MHS, Chief Use of cord blood therapy for perinatal asphyxia; use of genomic studies to diagnose and guide neonatal therapy
Samia Aleem, MBBS Neonatal infections, chronic lung disease, improving the care and outcomes of infants with congenital diaphragmatic hernias
Kamlesh Vasant Athavale, MBBS Neonatal ventilation, care of the premature infant
Eric Benner, MD, PhD Neural stem cell fate determination with a focus on oligodendrocyte specification following premature birth or perinatal brain injury; technology to noninvasively control neural circuits during development to investigate how altered neural activity impacts oligodendrocyte maturation; novel therapeutic approaches to mitigate myelin injury in high-risk infant population
Margarita Bidegain, MD, MHS Perinatal and neonatal palliative care, health disparities in perinatal care, neonatal sepsis and antibiotics, neuro neonatal intensive care
Trevor Deon Burt, MD

Human immune system development, mechanisms of fetal-maternal tolerance, fetal and neonatal immune response to infections, immunopathogenesis of preterm labor, use of ES and iPS cell technologies to study immune development

Jeffrey Ferranti, MD, MS Use of medical informatics, computerized patient safety initiatives
Kimberley Fisher, PhD, FNP-BC Use of cord blood therapy for perinatal asphyxia; evidence-based practices and management of clinical research in the NICU environment
Ronald N. Goldberg, MD Perinatal asphyxia; use of stem cell/cord blood therapy for perinatal asphyxia
Rachel Greenberg, MD, MHS

Pharmacology and infectious diseases in infants, differences in drug dosing between infants and older children and adults, drug safety and efficacy in infants, the impact of infection on infants in the neonatal intensive care unit, strategies to reduce the risk for developing infections in infants

Chi Dang Hornik, PharmD, BCPS Clinical pharmacology of infants and children, including pharmacokinetics and pharmacodynamics, drug safety and efficacy, medication safety practices
Susan Diane Flynn Izatt, MD Medical education including innovative teaching strategies and curriculum design
Deesha D. Mago-Shah, MD Improving and expanding the Transitional Medical Home for medically complex and fragile infants, care coordination and transition of care for medically complex infants, convalescent care of chronically ill neonates, neurodevelopmental follow-up of high risk infants, feeding problems in preterm and high risk term infants, including use of naso-gastric tubes to expedite hospital discharge and medical education and mentorship.
William Ferris Malcolm, MD Diagnosis and management of gastroesophageal reflux
Jennifer Hope Peterson, MD Milrinone in congenital diaphragmatic hernia, patent ductus arteriosus in premature infants, darbepoetin to improve red cell mass and neuroprotection in preterm infants
Sharla Marie Rent, MD Care and quality improvement practices to globally improve neonatal outcomes
P. Brian Smith, MD, MHS

Neonatal pharmacology, drug safety, environmental factors impacting child health, nosocomial infections, neonatal candidiasis

David T. Tanaka, MD Health care economics
Yui-Lin Tang, BM, MHS Infant nutrition and growth, convalescent and developmental care of premature infants
Mollie Gross Warren, MD TBD
Kristin Elizabeth Weimer, MD, PhD Preventing and/or identifying cytomegalovirus (CMV) and other infections in neonates to facilitate better outcomes, expansion of newborn screening
Noelle Young, MD Neonatal microbiome and metabolism, postnatal growth failure, human milk, outcomes of extremely preterm infants

Clinical Research

  • Problems of low birth weight infants, morbidity and mortality, perinatal asphyxia, ventilatory management, growth and development of high-risk infants, and the role of genomics in neonatal morbidity
  • Neurodevelopmental outcomes of high-risk infants.

Basic Research

  • Causes of birth defects that particularly affect the cardio-craniofacial field and left-right cardiac axis determination
  • Perinatal mechanisms of disrupted development and post-natal injury with special emphasis on lung, brain, and heart 

Translational Research

  • Neonatal pulmonary hypertension, pulmonary injury, and lung function

Health Care Economics Research

  • Medical economics, and biomedical engineering, specifically, in the areas of informatics, optics, virtual reality and microdigital fluidics

The Jean and George Brumley Jr. Neonatal Perinatal Research Institute (NPRI)

The Jean and George Brumley Jr. Neonatal Perinatal Research Institute (NPRI) aims to provide a dedicated environment wherein investigators from different fields can participate in collaborative multidisciplinary research aimed at understanding the basis of key problems suffered by neonates. 

Learn more

National Institute of Child Health and Human Development (NICHD) Neonatal Research Network

The Duke Division of Neonatology is a member of the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network, a consortium of the leading neonatal intensive care units in the country that perform cutting-edge, collaborative clinical research.

Learn more

Clinical Trials - Neonatal-Perinatal Research Unit (NPRU)

In the Division of Neonatology, we continually seek to improve health care practices by conducting clinical research, which includes our membership with the NICHD. We have many ongoing clinical trials in our Intensive Care Nursery (ICN). The Neonatal-Perinatal Research Unit (NPRU) provides the professional infrastructure to complete these studies. The operations director of the NPRU is Kimberley Fisher, PhD. Dr. Fisher is assisted by six study coordinators as well as other support staff that contribute to the success of clinical trials. 

Learn more